227 related articles for article (PubMed ID: 33334631)
1. [Management of multirefractory immune thrombocytopenia].
Mahévas M; Audia S; Viallard JF
Rev Med Interne; 2021 Jan; 42(1):46-49. PubMed ID: 33334631
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.
Mahévas M; Gerfaud-Valentin M; Moulis G; Terriou L; Audia S; Guenin S; Le Guenno G; Salles G; Lambotte O; Limal N; Viallard JF; Cheze S; Tomowiak C; Royer B; Neel A; Debouverie O; Hot A; Durieu I; Perlat A; Cliquennois M; Deteix C; Michel M; Godeau B
Blood; 2016 Sep; 128(12):1625-30. PubMed ID: 27354722
[TBL] [Abstract][Full Text] [Related]
3. Markers of refractory primary immune thrombocytopenia.
Moulis G; Garabet L
Br J Haematol; 2023 Oct; 203(1):112-118. PubMed ID: 38019080
[TBL] [Abstract][Full Text] [Related]
4. ITP and international guidelines: what do we know, what do we need?
Rodeghiero F; Ruggeri M
Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
6. [Immune thrombocytopenia: From pathogenesis to treatment].
Audia S; Mahevas M; Bonnotte B
Rev Med Interne; 2021 Jan; 42(1):16-24. PubMed ID: 32741715
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of ITP and AIHA in CVID: A systematic literature review].
Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
[TBL] [Abstract][Full Text] [Related]
9. Current approaches for the diagnosis and management of immune thrombocytopenia.
Gafter-Gvili A
Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
[TBL] [Abstract][Full Text] [Related]
10. Immune thrombocytopenia.
Bussel J; Cooper N; Boccia R; Zaja F; Newland A
Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
[TBL] [Abstract][Full Text] [Related]
11. Immune Thrombocytopenia in Children: Consensus and Controversies.
Singh G; Bansal D; Wright NAM
Indian J Pediatr; 2020 Feb; 87(2):150-157. PubMed ID: 31927692
[TBL] [Abstract][Full Text] [Related]
12. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.
Crickx E; Mahévas M; Michel M; Godeau B
Clin Interv Aging; 2023; 18():115-130. PubMed ID: 36726813
[TBL] [Abstract][Full Text] [Related]
13. Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content.
Revilla N; Corral J; Miñano A; Mingot-Castellano ME; Campos RM; Velasco F; Gonzalez N; Galvez E; Berrueco R; Fuentes I; Gonzalez-Lopez TJ; de la Morena-Barrio ME; Gonzalez-Porras JR; Vicente V; Lozano ML
Platelets; 2019; 30(6):743-751. PubMed ID: 30296193
[TBL] [Abstract][Full Text] [Related]
14. [Controversies in the treatment of paediatric immune thrombocytopenia].
Berrueco R; Dapena JL; Sebastián E; Sastre A
An Pediatr (Engl Ed); 2018 Sep; 89(3):189.e1-189.e8. PubMed ID: 30033108
[TBL] [Abstract][Full Text] [Related]
15. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN
Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087
[TBL] [Abstract][Full Text] [Related]
16. Is splenectomy a good strategy for refractory immune thrombocytopenia in adults?
Godeau B
Br J Haematol; 2023 Oct; 203(1):86-95. PubMed ID: 37735555
[TBL] [Abstract][Full Text] [Related]
17. Current and emerging treatments for immune thrombocytopenia.
Dou X; Yang R
Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
[No Abstract] [Full Text] [Related]
18. Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
Lv Y; Shi H; Liu H; Zhou L
Front Immunol; 2022; 13():953716. PubMed ID: 36003388
[TBL] [Abstract][Full Text] [Related]
19. Sequence of treatments for adults with primary immune thrombocytopenia.
George JN
Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032
[TBL] [Abstract][Full Text] [Related]
20. Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Jachiet V; Moulis G; Hadjadj J; Seguier J; Laribi K; Schleinitz N; Vey N; Sacre K; Godeau B; Beyne-Rauzy O; Bouvet R; Broner J; Brun N; Comont T; Gaudin C; Lambotte O; Le Clech L; Peterlin P; Roy-Peaud F; Salvado C; Versini M; Isnard F; Kahn JE; Gobert D; Adès L; Fenaux P; Fain O; Mekinian A
Haematologica; 2021 May; 106(5):1414-1422. PubMed ID: 33626866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]